| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q1 2021 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| iShares Comex Gold Trust | 17 | Q2 2017 | 18.2% |
| iShares MSCI ACWI ex-US Index | 17 | Q2 2017 | 33.9% |
| iShares MSCI ACWI Index | 17 | Q2 2017 | 49.4% |
| Exxon Mobil Corporation | 17 | Q2 2017 | 0.9% |
| HCA Healthcare Co | 17 | Q2 2017 | 0.5% |
| iShares Barclays Agg Bond | 17 | Q2 2017 | 1.7% |
| Cullen/Frost Bankers Inc. | 17 | Q2 2017 | 0.5% |
| Coca Cola Company | 17 | Q2 2017 | 0.6% |
| Procter & Gamble | 17 | Q2 2017 | 0.4% |
| Eli Lilly & Company | 17 | Q2 2017 | 0.4% |
View RONALD BLUE & CO LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| BlackRock Fund Advisors | February 13, 2015 | 2,565,759 | 5.7% |
| ETF Series Solutions | February 13, 2015 | 29,024,110 | 97.1% |
| ETF Series Solutions | February 13, 2015 | 10,580,694 | 95.3% |
| ETF Series Solutions | February 13, 2015 | 7,213,470 | 97.5% |
View RONALD BLUE & CO LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2017-07-28 |
| 13F-HR | 2017-05-10 |
| 13F-HR | 2017-02-01 |
| 13F-HR | 2016-10-17 |
| 13F-HR | 2016-08-10 |
| 13F-HR | 2016-05-13 |
| 13F-HR | 2016-02-11 |
| 13F-HR | 2015-11-13 |
| 13F-HR | 2015-08-11 |
| 13F-HR | 2015-05-12 |
View RONALD BLUE & CO LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.